Department of Chemical and Materials Engineering, Chang Gung University, Kwei-San, Taoyuan 33302, Taiwan, China.
Department of Plastic and Reconstructive Surgery and Craniofacial Research Center, Chang Gung Memorial Hospital, Kwei-San, Taoyuan 33305, Taiwan, China.
Curr Pharm Des. 2019;25(13):1490-1504. doi: 10.2174/1389203720666190521114936.
MNPs find numerous important biomedical applications owing to their high biocompatibility and unique magnetic properties at the bottom level. Among several other biomedical applications, MNPs are gaining importance in treating various kinds of cancer either as a hyperthermia agent alone or as a drug/gene carrier for single or combined therapies. At the same time, another type of nano-carrier with lipid bilayer, i.e. liposomes, has also emerged as a platform for administration of pharmaceutical drugs, which sees increasing importance as a drug/gene carrier in cancer therapy due to its excellent biocompatibility, tunable particle size and the possibility for surface modification to overcome biological barriers and to reach targeted sites. MLs that combine MNPs with liposomes are endowed with advantages of both MNPs and liposomes and are gaining importance for cancer therapy in various modes. Hence, we will start by reviewing the synthesis methods of MNPs and MLs, followed by a comprehensive assessment of current strategies to apply MLs for different types of cancer treatments. These will include thermo-chemotherapy using MLs as a triggered releasing agent to deliver drugs/genes, photothermal/ photodynamic therapy and combined imaging and cancer therapy.
MNPs 由于其高生物相容性和独特的磁性特性,在基础层面上找到了许多重要的生物医学应用。在其他几种生物医学应用中,MNPs 作为单独的热疗剂或作为药物/基因载体用于单一或联合治疗,在治疗各种癌症方面变得越来越重要。与此同时,另一种具有脂质双层的纳米载体,即脂质体,也已经成为药物给药的平台,由于其优异的生物相容性、可调的粒径以及表面修饰以克服生物屏障和到达靶向部位的可能性,作为药物/基因载体在癌症治疗中的重要性日益增加。将 MNPs 与脂质体结合的 MLs 兼具 MNPs 和脂质体的优势,并且正在以多种模式应用于癌症治疗。因此,我们将首先回顾 MNPs 和 MLs 的合成方法,然后全面评估目前将 MLs 应用于不同类型癌症治疗的策略。这些策略包括将 MLs 用作触发释放剂的热化疗,以递送药物/基因,光热/光动力治疗以及联合成像和癌症治疗。
Curr Pharm Des. 2019
Curr Drug Metab. 2015
Nanotechnology. 2019-12-6
Nanomedicine (Lond). 2017-2
Adv Colloid Interface Sci. 2019-1-23
Cancer Pathog Ther. 2024-12-9
J Funct Biomater. 2024-8-14
Pharmaceutics. 2023-10-11
Micromachines (Basel). 2022-8-8